No More Finger Pricks: Blood Center Adopts Painless Hemoglobin Testing

Painless hemoglobin testing device on a fingertip.
Table of Contents
    Add a header to begin generating the table of contents

    ImpactLife blood center is revolutionizing the donation process by introducing a new non-invasive technology that eliminates the need for finger pricks during pre-screening. This innovative approach promises a more comfortable experience for donors while also reducing medical waste.

    Key Takeaways

    • ImpactLife blood center has implemented a new non-invasive testing device called OrSense.
    • The technology uses light to measure hemoglobin levels, replacing the traditional finger prick.
    • This change aims to improve donor comfort and decrease bio-hazardous waste.

    A Painless Pre-Screening Process

    Blood donors at ImpactLife can now look forward to a less invasive pre-screening experience. The center has adopted the OrSense device, a cutting-edge technology designed to assess hemoglobin levels without the need for a finger prick. This advancement marks a significant step forward in making the blood donation process more comfortable and accessible for everyone.

    How the Technology Works

    The OrSense device utilizes a sophisticated sensor that shines light through the skin. This light allows the device to accurately measure the donor’s hemoglobin level, a crucial factor in determining blood donation eligibility. By employing this non-invasive method, ImpactLife ensures that donors can be screened efficiently and comfortably.

    Benefits Beyond Donor Comfort

    In addition to enhancing the donor experience, the introduction of OrSense technology brings environmental benefits. The elimination of finger pricks means a reduction in the use of disposable medical supplies such as lancets, gloves, and bandages. This contributes to a decrease in bio-hazardous waste, aligning with ImpactLife’s commitment to sustainable practices.

    Availability Across Locations

    This new, pain-free testing method is already in use at ImpactLife’s facilities located in Davenport, Iowa City, and Cedar Rapids. Donors visiting these locations can expect to benefit from this advanced technology during their next donation.

    Sources